Apologies if the study has appeared before but if it has I haven't seen it, this would appear to be the most important paper on c60oo since Baati ten years ago and perhaps is the type of study we should have expected within a year or two after.
A thanks to the "Ministry of Education, Science and Technological Development of the Republic of Serbia" for funding this research.
https://www.ncbi.nlm...idants-10-00911
A couple of points to note the rats were fed ad libitum except for once a week they were fasted 16 hours. The estimated dietary consumption of olive oil was the human equivalent of 60 grams which for the two c60oo doses is an equivalent of something like 65mg and 13 mg, respectively. The questions as to whether the c60 translates allometrically to the olive oil equivalent as has been queried previously since we're trying to put c60 in the cells of mitochondria rather than scaling up a biological system.
However, the take home message, of the toxiciology study is, when it comes to c60oo, less is more - as has been discussed before, consistent with Turnbuckle's observations. Unfortunately, there was no c60oo control which would have been great and we only have two c60oo points on a plot subject to a toxic effect and it would seem reasonable to assume optimisitcally that the lower dose isn't the best and concerningly the high dose not the worst.
No human that we know of has taken several litres a month and the human equivalent of the study wrt c60 might be much higher than that for either dose.
Anyhow, a great study with a comprehensive set of metrics. Some observations:
One of the stand out results, I thought, was the effect of c60oo on the DNA comet tail of the rats. The comet tail of the non-intervention rats increased by 240% compared to controls; olive oil alone resulted in a 100% increase over controls and the high c60oo dose just 10%. However, despite the Thioacetamide, the low dose c60oo group saw a reduction in tail length of around 25 % over the unexposed controls.
Catalase was another noteworthy metric. In three of the four exposed groups, including the c60oo high dose arm, Catalase expression was reduced but with low dose c60 Catalase was up nearly 30%.
Body mass of all exposed groups were considerably lower than controls. The low dose c60 group, still 15% lower than controls fared the best while the high c60 dose group the worst, down 25%. Water intake saw closeness amongst all exposed groups, well off controls, save the high c60oo dose group, consuming over 10% less than the low dose group.
The sampled images of the livers, which of course likely were not random, were quite revealing - the low dose c60 and control group were similar and the only two appearing healthy - the liver protective effects of c60oo was an observation made from Baati.
There too was indication of increased glycemia which it is posited is due to self-aggregation of c60 leading to pro-oxidation.
C60oo low dose appeared to offer protection against cancer in exposed groups (4 from 8), while high dose c60oo offered none compared to untreated group (6/8), olive oil fared the worst (8/8).
Suggestion of deleterious effects of olive oil on the liver given parenchymal injury, fibrosis, and biliary injury and inflammation were also more prominent in the TAA+O group than all other experimental groups
"Our results showed that in comparison with the control group, treatment with TAA (alone or in combination with VOO) significantly increased the liver’s whole homogenate level of HMGB1 expression (3.2- and 3.3-fold, respectively), and consequently the level of phosphorylated NF-κB p65 (2.2- and 2-3-fold, respectively) . In comparison to the TAA+O rat group, in the TAA+F1 group, the expression level of HMGB1 and p-NF-κB p65 decreased by about 54% and 39%, respectively, while in TAA+F2-treated rats, only p-NF-κB p65 expression level decreased by about 22% . These results suggested that only a lower dose of C60 fullerene has the potential to inhibit activation of NF-κB p65 and, consequently, necrotic events in TAA-induced liver injury."
Obviously there are more observations, but will leave with A&S:
Abstract
"Thioacetamide (TAA) is widely used to study liver toxicity accompanied by oxidative stress, inflammation, cell necrosis, fibrosis, cholestasis, and hepatocellular carcinoma. As an efficient free radical’s scavenger, C60 fullerene is considered a potential liver-protective agent in chemically-induced liver injury. In the present work, we examined the hepatoprotective effects of two C60 doses dissolved in virgin olive oil against TAA-induced hepatotoxicity in rats. We showed that TAA-induced increase in liver oxidative stress, judged by the changes in the activities of SOD, CAT, GPx, GR, GST, the content of GSH and 4-HNE, and expression of HO-1, MnSOD, and CuZnSOD, was more effectively ameliorated with a lower C60 dose. Improvement in liver antioxidative status caused by C60 was accompanied by a decrease in liver HMGB1 expression and an increase in nuclear Nrf2/NF-κB p65 ratio, suggesting a reduction in inflammation, necrosis and fibrosis. These results were in accordance with liver histology analysis, liver comet assay, and changes in serum levels of ALT, AST, and AP. The changes observed in gut microbiome support detrimental effects of TAA and hepatoprotective effects of low C60 dose. Less protective effects of a higher C60 dose could be a consequence of its enhanced aggregation and related pro-oxidant role."
Conclusion
"In line with the increased interest in the use of nanotechnology for biomedical applications, we investigated the effects of potent free-radical scavenger C60 fullerene in TAA-induced rat liver injury. The obtained data indicated the dose-dependent hepatoprotective effects of C60. In a low dose, C60 fullerene was more efficient in terms of liver antioxidative and anti-inflammatory protection and reduced tissue fibrosis, necrosis, and CCC development. The ability of C60 to upregulate Nrf2 and downregulate HMGB1/NF-kB p65 signalling pathways could contribute to its actions. Our data also implicated that VOO may enhance toxic effects of TAA, which is why the development of water-soluble C60 derivates could be a more promising approach in its therapeutic use."
Edited by ambivalent, 07 December 2022 - 06:19 PM.